Cargando…

Plasma amyloid beta 40/42, phosphorylated tau 181, and neurofilament light are associated with cognitive impairment and neuropathological changes among World Trade Center responders: A prospective cohort study of exposures and cognitive aging at midlife

INTRODUCTION: World Trade Center (WTC) responders are experiencing a high risk of mild cognitive impairment (MCI) and dementia, though the etiology remains inadequately characterized. This study investigated whether WTC exposures and chronic post‐traumatic stress disorder (PTSD) were correlated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kritikos, Minos, Diminich, Erica D., Meliker, Jaymie, Mielke, Michelle, Bennett, David A., Finch, Caleb E., Gandy, Sam E., Carr, Melissa A., Yang, Xiaohua, Kotov, Roman, Kuan, Pei‐Fen, Bromet, Evelyn J., Clouston, Sean A. P., Luft, Benjamin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994167/
https://www.ncbi.nlm.nih.gov/pubmed/36911360
http://dx.doi.org/10.1002/dad2.12409
Descripción
Sumario:INTRODUCTION: World Trade Center (WTC) responders are experiencing a high risk of mild cognitive impairment (MCI) and dementia, though the etiology remains inadequately characterized. This study investigated whether WTC exposures and chronic post‐traumatic stress disorder (PTSD) were correlated with plasma biomarkers characteristic of Alzheimer's disease (AD) neuropathology. METHODS: Eligible participants included WTC‐exposed individuals with a baseline cognitive assessment and available plasma sample. We examined levels of the amyloid beta (Aβ)40/42 ratio, phosphorylated tau 181 (p‐tau181), and neurofilament light chain (NfL) and associations with a WTC exposures (duration on site ≥15 weeks, dust cloud), the PTSD Symptom Checklist for Diagnostic and Statistical Manual of Mental Disorders, 4th edition PTSD, and classification of amyloid/tau/neurodegeneration (AT[N]) profiles. Multinomial logistic regressions assessed whether biomarkers predicted increased risk of MCI or dementia. RESULTS: Of 1179 eligible responders, 93.0% were male, mean (standard deviation) age 56.6 years (7.8). Aβ40/42, p‐tau181, and NfL intercorrelated and increased with age. In subgroup analyses of responders with available neuroimaging data (n = 75), Aβ40/42 and p‐tau181 were further associated with decreased hippocampal volume (Spearman's ρ = −0.3). Overall, 58.08% of responders with dementia had ≥1 elevated biomarker, and 3.45% had elevations across all biomarkers. In total, 248 (21.05%) had MCI and 70 (5.94%) had dementia. Increased risk of dementia was associated with plasma AT(N) profile T+ or A+N+. Exposure on site ≥15 weeks was independently associated with T+ (adjusted risk ratio [aRR] = 1.03 [1.01−1.05], P = 0.009), and T+N+ profile (aRR = 2.34 [1.12−4.87]). The presence of PTSD was independently associated with risk of A+ (aRR = 1.77 [1.11−2.82]). DISCUSSION: WTC exposures and chronic PTSD are associated with plasma biomarkers consistent with neurodegenerative disease.